Omitting hemicolectomy for patients with appendiceal neuroendocrine tumours of 1-2 cm - Authors' reply
- PMID: 37142378
- DOI: 10.1016/S1470-2045(23)00114-6
Omitting hemicolectomy for patients with appendiceal neuroendocrine tumours of 1-2 cm - Authors' reply
Conflict of interest statement
We declare no competing interests.
Comment on
-
Hemicolectomy versus appendectomy for patients with appendiceal neuroendocrine tumours 1-2 cm in size: a retrospective, Europe-wide, pooled cohort study.Lancet Oncol. 2023 Feb;24(2):187-194. doi: 10.1016/S1470-2045(22)00750-1. Epub 2023 Jan 11. Lancet Oncol. 2023. PMID: 36640790
-
Omitting hemicolectomy for patients with appendiceal neuroendocrine tumours of 1-2 cm.Lancet Oncol. 2023 May;24(5):e187. doi: 10.1016/S1470-2045(23)00059-1. Lancet Oncol. 2023. PMID: 37142375 No abstract available.
-
Omitting hemicolectomy for patients with appendiceal neuroendocrine tumours of 1-2 cm.Lancet Oncol. 2023 May;24(5):e188. doi: 10.1016/S1470-2045(23)00098-0. Lancet Oncol. 2023. PMID: 37142376 No abstract available.
-
Omitting hemicolectomy for patients with appendiceal neuroendocrine tumours of 1-2 cm.Lancet Oncol. 2023 May;24(5):e189. doi: 10.1016/S1470-2045(23)00122-5. Lancet Oncol. 2023. PMID: 37142377 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources